Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

ARPA-H Emerging Health Innovators (EHI) Initiative

Active

ARPA-H-SOL-26-150Federal

Response Deadline02/10/2027, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

DC, 20003, USA

Set-Aside

NONE

Documents

(9)

ARPA-H-SOL-26-150 Emerging Health Innovators (EHI) Initiative

PDF•rfp

Attachment C: Technical and Management Proposal Template

DOCX•5 pages•specifications

Attachment E: Milestone Payment Schedule

DOCX•5 pages•specifications

ARPA-H Model Other Transaction Agreement

DOCX•24 pages•contract-document

Attachment B - EHI Pitch Slides Instructions

PPTX•2 pages•specifications

Attachment A - Solution Summary Template

DOCX•3 pages•specifications

Attachment D: Task Description Document (TDD) Template

DOCX•2 pages•sow

Attachment F: Administrative & National Policy Requirements Document

DOCX•13 pages•supporting-documents

ARPA-H-SOL-26-150 Emerging Health Innovators (EHI) Administrative FAQ

DOCX•4 pages•q-and-a

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation

PostedSep 15

Solicitation

Response DeadlineFeb 10

Submission deadline

Response Deadline

02/10/2027, 07:00:00 PM UTCin 5 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Contacts1 person available

OfficeWashington, DC, 20005, USA

Organization / Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

View Agency Profile

Office AddressWashington, DC, 20005, USA

Contacts

EHI Program Team

contact@example.gov

Full Description

Show more

The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) aims to or seeks to ensure ARPA-H identifies and engages early career investigators. To achieve this goal, ARPA-H is soliciting proposals from these researchers and
innovators and their organizations to develop cutting-edge biomedical, health, and community-engaged research and innovation. ARPA-H anticipates multiple Other Transaction awards resulting from this announcement

Similar Contracts

Same NAICS industry code

Proprietary Metabolomic Analysis and Small Molecule AuthenticationThis subcontract involves providing advanced metabolomic analysis of biological samples for prime contractors supporting USDA Agricultural Research Service projects. The work utilizes a proprietary chemocentric methodology to authenticate small molecules through the analysis of fragmentation patterns, accurate mass, and retention time. Execution of these services requires the use of liquid chromatography systems and high-resolution mass spectrometry to produce authenticated analysis reports and data sets. The project is associated with the Department of Agriculture under the USDA Ars Afm Apd agency and is categorized under NAICS code 541714. Performance of the contract is located in Raleigh, North Carolina. The solicitation was posted on September 15, 2026, with a response deadline of September 22, 2026.

USDA Ars Afm Apd

POSTED

about 24 hours ago

DEADLINE

Programmable Therapeutic Modality ResearchThe Programmable Therapeutic Modality Research subcontract, issued by the Advanced Research Projects Agency for Health (ARPA-H) under the Department of Health and Human Services, focuses on developing programmable therapeutic and countermeasure modalities. The primary objective is to investigate how microbial defense systems can be adapted for use in mammalian systems to address critical public health and national health security requirements. The selected provider will be responsible for delivering proof-of-concept therapeutic designs, modality adaptability data, and detailed technical reports. Due to the nature of the research, the contractor must maintain CUI handling capabilities and ensure full compliance with NSPM-33. This opportunity is categorized under NAICS code 541714, with a response deadline of February 10, 2027.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

about 24 hours ago

DEADLINE

Notice of Intent to Sole Source - Metabolomic Analysis

Solicitation # 1232SA26Q1503

The United States Department of Agriculture Agricultural Research Service intends to award a sole source firm fixed price contract for metabolomic analysis services to support the Soybean and Nitrogen Fixation Research Unit in Raleigh, North Carolina. The requirement specifies the use of a proprietary chemocentric methodology underpinned by over 145 patents, where small molecules must be authenticated using fragmentation patterns, accurate mass, and retention time. This effort falls under NAICS code 541714. This notice serves as an informational announcement rather than a formal solicitation for bids or proposals. Interested and capable sources must submit their technical capabilities and expression of interest via email to Frank Palmer at frank.palmer@usda.gov by September 22, 2026, at 1:00 pm Mountain Daylight Savings Time.

USDA Ars Afm Apd

POSTED

about 24 hours ago

DEADLINE

Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases

Solicitation # RFP-NIAID-DMID-75N98026R00169

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a Small Business Sources Sought notice to identify qualified small business sources capable of establishing and managing a Statistical and Data Coordinating Center (SDCC). The SDCC will support extramural clinical research programs, specifically focusing on Phase 0-4 clinical trials for therapeutics, vaccines, and diagnostics related to infectious, immunologic, and allergic diseases. Key requirements include 21 CFR Part 11-compliant data management, statistical design and analysis, specimen tracking, and the integration of AI tools subject to human review and quality control. The government anticipates a single contract award with a maximum duration of seven years, estimating an initial requirement of 60 full-time equivalents per year with options for up to 90 additional FTEs. Interested small businesses must submit a tailored capability statement by September 30, 2026, demonstrating their expertise in clinical data systems, regulatory compliance, and project management. This notice is intended for market research to determine the appropriate acquisition method and potential set-asides and is not a formal solicitation for proposals.

National Institutes Of Health Niaid

POSTED

about 24 hours ago

DEADLINE

Biological Technologies Investment and R&DThe Biological Technologies Investment and R&D subcontract, issued by the Defense Advanced Research Projects Agency under the Department of Defense, focuses on performing biotechnology research for prime contractors on DARPA Venture Horizons projects. The scope of work includes the development of biosensors, operational resilience systems, functional restoration technologies, and tactical warfighter care solutions. To be successful, the provider must possess specialized expertise in logistical security and medical device engineering to deliver technical research and investment-ready biotech frameworks. This opportunity was posted on September 14, 2026, with a response deadline of October 9, 2026. It is categorized under NAICS code 541714, reflecting its focus on research and development in the biotechnology sector.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Solicitation # W911SR-26-9-CADENCC

The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.

POSTED

DEADLINE

Notice of Intent to Award to a Single Source

Solicitation # PCA-NIDCD-09517

The National Institutes of Health Office of the Director Office of Acquisitions intends to award a single-source contract to the University of Illinois School of Chemical Sciences for the procurement of K101 and K110 pellets. These pellets are required by the National Institute on Deafness and Other Communication Disorders to ensure a superior steady-state, slow-release of study compounds over 90-day periods. The government has identified the University of Illinois as the sole source capable of providing the necessary quality and consistency required to maintain the integrity of ongoing study data, as commercial alternatives have proven unmatched. This notice serves as a pre-solicitation under the authority of 41 U.S.C. 3204(b)(2), and is not a formal request for proposal. However, interested vendors may submit capability statements and past performance documentation to Christine Biser by September 16, 2026, referencing solicitation PCA-NIDCD-09517. The government will evaluate these submissions to determine if the procurement should be conducted on a competitive basis, though the final decision remains at the discretion of the agency.

National Institutes Of Health

POSTED

DEADLINE

Whole genome sequencing for investigation of age-related chronic disease in HANDLS participants

Solicitation # 75N98026R00166

National Institutes Of Health Olao

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Genome Characterization Centers initiative. Building upon the multi-omic datasets established in Stage 1, this program aims to advance the understanding of biological processes and disease mechanisms driven by somatic mutations across various human tissues. The primary objective of the Stage 2 centers is to determine the functional consequences of somatic mutations within both healthy and clinically relevant tissue samples, specifically focusing on patients whose phenotypes are suspected to be driven by these mutations. This effort is designed to further characterize somatic mosaicism and its broader role in human biology and disease.

National Institutes Of Health

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for the Somatic Mosaicism across Human Tissues (SMaHT) Program focusing on Experimental and Computational Technology Development. This initiative aims to advance the understanding of biological processes and disease mechanisms by developing, optimizing, and validating cost-effective technologies for somatic mutation detection and functional interpretation. Building upon the multi-omic datasets established in Stage 1, this second stage emphasizes the creation of rigorous benchmarks and the dissemination of tools to support the discovery of mutations across human tissues. Awardees will be expected to work collaboratively with other SMaHT Stage 2 initiatives to integrate these validated technologies into production workflows, data releases, and broader community resources. This multidisciplinary effort is designed to enhance the detection and analysis of somatic mutations across all three germ layers. Interested parties can contact the SMaHT Program via email for further information regarding this opportunity.

National Institutes Of Health

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)The National Institutes of Health is seeking support for Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Network through the establishment of the National Somatic Mosaicism Commons Data Analysis and Organizational Center. This initiative aims to advance the understanding of biological processes and disease mechanisms by leveraging multi-omic somatic mutation datasets from human tissues across all three germ layers. The Center will serve as a central hub for network governance, coordination, and the development of tools and platforms designed for both network members and the broader clinical and research communities. Key responsibilities of the Center include managing network data and creating essential resources such as the SMaHT data portal, a Variant Catalog, a variant browser, and various visualization tools. Additionally, the Center will provide analysis-ready data releases and lead outreach and training efforts to ensure the research community can effectively utilize these complex datasets. This forecasted opportunity is managed by the Department of Health and Human Services and specifically prohibits clinical trials.

National Institutes Of Health

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and a commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Contractors are required to produce these countermeasures against influenza and other viruses with pandemic potential, generate and submit all necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data to the FDA, and support rapid regulatory decisions. To be eligible, offerors must hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by a Biologics License Application submission. The contract is structured as an IDIQ with a five-year base period and a potential five-year option period, totaling a possible 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a significant emphasis on capabilities. Key requirements include strict adherence to CGMP guidelines, the implementation of comprehensive business and supply continuity plans, and the submission of surge manufacturing and supply chain readiness assessments. Deliverables include the preparation of candidate vaccine viruses and the management of complex logistics, including temperature-controlled shipping and specific packaging standards. Payment is processed quarterly via the Department of Treasury Invoice Processing Platform.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

Human or Animal Subjects Research SupportThis subcontract for the Advanced Research Projects Agency for Health (ARPA-H) involves providing biological testing support for prime contractors through the execution of in-vivo or in-vitro studies. The selected provider will be responsible for managing subject protocols and delivering validated experimental data along with comprehensive clinical or pre-clinical reports. To qualify, the contractor must utilize facilities approved by the IRB or IACUC, and all key personnel are required to complete mandatory Human Subjects Research or Animal Subjects Research training. This opportunity, categorized under NAICS code 115210, has a response deadline of February 10, 2027.

Support Activities for Animal Production

POSTED

about 24 hours ago

DEADLINE

Structural Dataset Generation and Predictive ModelingThis subcontract for the Advanced Research Projects Agency for Health under the Department of Health and Human Services focuses on the generation of foundational structural datasets and design rules for non-nucleic acid-templated DNA synthesis. The project utilizes high-performance computing and bioinformatics software to advance predictive structural modeling, with a requirement for the delivery of structural datasets, predictive models, and specific DNA synthesis design rules. The work is categorized under NAICS code 541715 and requires strict adherence to open-source software standards and the handling of Controlled Unclassified Information. Interested parties must submit their responses by February 10, 2027, for performance in the 20003 zip code area.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 24 hours ago

DEADLINE

DRT-Enabled Diagnostic and Sensing DevelopmentThe DRT-Enabled Diagnostic and Sensing Development subcontract, issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services, focuses on creating novel diagnostic, sensing, and biochemical functions for prime contractors. The scope of work involves designing biochemical sensors and utilizing protein-templated DNA synthesis to accelerate the development of therapeutics. Key deliverables include functional diagnostic prototypes, biochemical sensing assays, and comprehensive technical performance data. To qualify, providers must possess advanced biochemistry laboratory facilities and maintain the capability to handle Controlled Unclassified Information while ensuring compliance with NSPM-33. This opportunity, categorized under NAICS code 541715, was posted on September 15, 2026, with a response deadline of February 10, 2027. Performance is centered in the 20003 zip code area.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 24 hours ago

DEADLINE

Restorative and health-Enhancing Sleep Time (REST)

Solicitation # ARPA-H-SOL-26-159

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative proposals under the Restorative and health-Enhancing Sleep Time (REST) program to revolutionize sleep health through objective, home-based, closed-loop technologies that detect and respond to sleep microstructures in real time. The program aims to reduce by at least 50% the 10-year risk of chronic diseases linked to poor sleep—including dementia, depression, cardiovascular disease, and type 2 diabetes—by developing validated systems that measure, diagnose, and treat sleep dysfunction with precision. The technical scope is divided into two areas: Technical Area 1 (TA1) focuses on creating in-home systems for objective measurement and mechanistic classification of poor sleep using physiological signals, while Technical Area 2 (TA2) targets the development of integrated, noninvasive, closed-loop interventions that adapt in real time to individual sleep physiology to improve outcomes. The program is structured into three phased milestones over 66 months—Prove Tech (24 months), Proof-of-Concept (18 months), and Translation (24 months)—with specific technical benchmarks including AUC thresholds for insomnia diagnosis, sensitivity/specificity targets for sleep classification, and Pearson correlation standards for fidelity to polysomnography. Key milestones include IRB approvals by month 3, human subject enrollment by month 12, technology validation and FDA submissions by month 39, and final site visits and demonstrations between months 63 and 66. Proposals must be submitted in two stages: a Solution Summary, due by August 12, 2026, at 12pm ET, and a Full Proposal for those invited to proceed. The Solution Summary must be submitted via https://solutions.arpa-h.gov/events, adhere to strict formatting rules including 12-point Avenir Next LT Pro font, and comply with page limits of six pages for single TA or eight pages for both TAs, excluding cover pages, basis of estimate, cost share strategy, and citations. Only invited proposers may submit a Full Proposal, which includes an in-person pitch—45 minutes for one TA or 60 minutes for both—and supporting documentation divided into five volumes: a four-page Technical Proposal, an unrestricted Cost/Price Proposal, a two-page Human or Animal Subjects Research section, a Data Management and Security Plan, and up to five pages of qualifications per key personnel. Evaluation is based on scientific and technical merit, feasibility, innovation, proposer capability, and budget

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 24 hours ago

DEADLINE

Clinical Validation and FDA Regulatory AffairsThis subcontract for Clinical Validation and FDA Regulatory Affairs supports prime contractors on ARPA-H REST projects within the Department of Health and Human Services. The scope of work involves the design and management of pilot and pivotal FDA trials, including patient recruitment and the analysis of clinical data to ensure specific AUC and sensitivity metrics are met. The selected provider must adhere to Good Clinical Practice and FDA regulatory submission standards to deliver comprehensive clinical trial reports, validated performance data, and FDA submission dossiers. The opportunity was posted on September 14, 2026, with a response deadline of October 13, 2026, under NAICS code 541611.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Noninvasive Closed-Loop Sleep Treatment SystemsThis subcontract involves the engineering of noninvasive, closed-loop sleep treatment systems for prime contractors working on ARPA-H REST projects. The primary objective is to develop adaptive control systems that utilize real-time physiological data to treat insomnia through noninvasive stimulation hardware. The scope of work includes the execution of pilot efficacy trials and the preparation of pivotal trial submissions for the FDA Center for Devices and Radiological Health. The final deliverables consist of a functional treatment device and a complete FDA submission package.

Electronic Computer Manufacturing

POSTED

DEADLINE

Sleep Physiology Measurement & Diagnostic SystemsThis subcontract under the Advanced Research Projects Agency for Health (ARPA-H) focuses on the development and validation of in-home systems designed for the objective measurement of sleep-relevant physiology. The project involves designing specialized hardware and software for insomnia diagnosis, performing prospective validation of health predictions, and conducting rigorous fidelity testing against Polysomnography standards. The primary objective is to deliver a validated in-home diagnostic system capable of screening and treatment matching. This effort requires the integration of in-home physiological sensors and diagnostic software to support prime contractors on ARPA-H REST projects. The opportunity was posted on September 14, 2026, with a response deadline of October 13, 2026, under NAICS code 541715.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program

Solicitation # 7599226SN106

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns (SBCs) for its Fiscal Year 2026 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. This total small business set-aside initiative aims to stimulate technological innovation and increase private sector commercialization of health-related research. Eligible SBCs must be for-profit entities located in the United States with no more than 500 employees. The program is structured in phases, focusing on feasibility and full research and development, with a strong emphasis on commercialization and the achievement of measurable milestones such as regulatory submissions or strategic partnerships. The solicitation covers seven specific research topics: annual fertility testing for women, versatile bioadhesives, a universal synthetic biology platform for toxin removal, non-surgical therapies for endometriosis, the advancement of ARPA-H lineage technologies, rapid diagnostics for multi-system autoimmune disease, and a virtual human brain for neurosurgical robotics. The submission process is conducted in two stages via the ARPA-H Solutions site. Stage 1 requires a solution summary and administrative uploads, while invited proposers in Stage 2 must provide a technical presentation, a Task Description Document, a Gantt chart, and a detailed cost proposal. Awards are based on technical merit, novelty, team experience, path to impact, and availability of funds, subject to security risk assessments by the HHS Due Diligence Program. Proposers must maintain active SAM.gov registration and provide a Unique Entity Identifier at Stage 2. The program provides Technical and Business Assistance (TABA) funding of up to 6,500 dollars for Phase I and up to 50,000 dollars for Phase II. All deliverables must comply with Revised 508 Standards for accessibility, and any proprietary data must be delivered with specific restrictive markings to protect SBIR/STTR data rights.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Commercialization Support & Strategy

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Community-Engaged Health Research

Research and Development in the Social Sciences and Humanities

POSTED

DEADLINE

Biomedical Research & Development

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS